HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients.
Zhu X, Zhang Y, Bai Y, Gu X, Chen G, Sun L, Wang Y, Qiao X, Ma Q, Zhu T, Bu J, Xue J, Liu C.
Zhu X, et al. Among authors: zhu t.
Int J Med Sci. 2020 Sep 30;17(17):2773-2789. doi: 10.7150/ijms.43161. eCollection 2020.
Int J Med Sci. 2020.
PMID: 33162805
Free PMC article.